Here are three quick points: 1. Vericel is a developer of patient-specific expanded cellular therapies. 2. Matricel is a developer, manufacturer and marketer of medical devices and pharmaceutical excipients, including biocompatible matrices in regenerative medicine. 3. The agreement is related to the United States registration of the ACI-Maix collagen membrane used in the manufacture of MACI, which is Vericel's investigational third-generation autologous-cultured chondrocyte implant. More articles on devices: 500th Navio knee surgery performed at Cornerstone Regional Hospital: 5 key notes Alphatec Spine, LDR, Globus Medical & more — 21 key notes DJO Surgical unveils its EMPOWR 3D Knee system: 5 points